Skip to main content
Top
Published in: Critical Care 5/2005

01-10-2005 | Review

Year in review: Critical Care 2004 – nephrology

Authors: Zaccaria Ricci, Claudio Ronco

Published in: Critical Care | Issue 5/2005

Login to get access

Abstract

We summarize all original research in the field of critical care nephrology published in 2004 or accepted for publication in Critical Care and, when considered relevant or directly linked to this research, in other journals. Articles were grouped into four categories to facilitate a rapid overview. First, regarding the definition of acute renal failure (ARF), the RIFLE criteria (risk, injury, failure, loss, ESKD [end-stage kidney disease]) for diagnosis of ARF were defined by the Acute Dialysis Quality Initiative workgroup and applied in clinical practice by some authors. The second category is acid–base disorders in ARF; the Stewart–Figge quantitative approach to acidosis in critically ill patients has been utilized by two groups of researchers, with similar results but different conclusions. In the third category – blood markers during ARF – cystatin C as an early marker of ARF and procalcitonin as a sepsis marker during continuous venovenous haemofiltration were examined. Finally, in the extracorporeal treatment of ARF, the ability of two types of high cutoff haemofilters to influence blood levels of middle- and high-molecular-weight toxins showed promise.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ronco C: Acute Dialysis Quality Initiative (ADQI): the PASSPORT project. Int J Artif Organs 2005, 28: 438-440.PubMed Ronco C: Acute Dialysis Quality Initiative (ADQI): the PASSPORT project. Int J Artif Organs 2005, 28: 438-440.PubMed
2.
go back to reference Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, the ADQI workgroup: Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004, 8: R204-R212. 10.1186/cc2872PubMedCentralCrossRefPubMed Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, the ADQI workgroup: Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004, 8: R204-R212. 10.1186/cc2872PubMedCentralCrossRefPubMed
3.
go back to reference National Kidney Foundation: K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification. Am J Kidney Dis 2002, (Suppl 1):S76-S92. National Kidney Foundation: K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification. Am J Kidney Dis 2002, (Suppl 1):S76-S92.
4.
go back to reference Hoste E, Clermont G, Kersten A, Venkataraman R, Kaldas H, Angus D, Kellum JA: Clinical evaluation of the new RIFLE criteria for acute renal failure. 24th International Symposium on Intensive Care and Emergency Medicine. Crit Care 2004, (Suppl 1):P161. Hoste E, Clermont G, Kersten A, Venkataraman R, Kaldas H, Angus D, Kellum JA: Clinical evaluation of the new RIFLE criteria for acute renal failure. 24th International Symposium on Intensive Care and Emergency Medicine. Crit Care 2004, (Suppl 1):P161.
5.
go back to reference Bell M, Liljestam E, Granath F, Fryckstedt J, Ekbom A, Martling C: Optimal follow-up time after Continuous renal replacement therapy in actual renal failure patients stratified with the RIFLE criteria. Nephrol Dial Transplant 2005, 20: 354-360. 10.1093/ndt/gfh581CrossRefPubMed Bell M, Liljestam E, Granath F, Fryckstedt J, Ekbom A, Martling C: Optimal follow-up time after Continuous renal replacement therapy in actual renal failure patients stratified with the RIFLE criteria. Nephrol Dial Transplant 2005, 20: 354-360. 10.1093/ndt/gfh581CrossRefPubMed
6.
go back to reference Naka T, Bellomo R: Bench-to-bedside review: Treating acid–base abnormalities in the intensive care unit – the role of renal replacement therapy. Crit Care 2004, 8: 108-114. 10.1186/cc2821PubMedCentralCrossRefPubMed Naka T, Bellomo R: Bench-to-bedside review: Treating acid–base abnormalities in the intensive care unit – the role of renal replacement therapy. Crit Care 2004, 8: 108-114. 10.1186/cc2821PubMedCentralCrossRefPubMed
8.
go back to reference Gehlbach BK, Schmidt GA: Bench-to-bedside review: Treating acid–base abnormalities in the intensive care unit – the role of buffers. Crit Care 2004, 8: 259-265. 10.1186/cc2865PubMedCentralCrossRefPubMed Gehlbach BK, Schmidt GA: Bench-to-bedside review: Treating acid–base abnormalities in the intensive care unit – the role of buffers. Crit Care 2004, 8: 259-265. 10.1186/cc2865PubMedCentralCrossRefPubMed
9.
go back to reference Kellum JA, Song M, Li J: Science review: Extracellular acidosis and the immune response: clinical and physiologic implications. Crit Care 2004, 8: 331-336. 10.1186/cc2900PubMedCentralCrossRefPubMed Kellum JA, Song M, Li J: Science review: Extracellular acidosis and the immune response: clinical and physiologic implications. Crit Care 2004, 8: 331-336. 10.1186/cc2900PubMedCentralCrossRefPubMed
11.
go back to reference Morgan TJ: Clinical review: The meaning of acid–base abnormalities in the intensive care unit – effects of fluid administration. Crit Care 2005, 9: 204-211. 10.1186/cc2946PubMedCentralCrossRefPubMed Morgan TJ: Clinical review: The meaning of acid–base abnormalities in the intensive care unit – effects of fluid administration. Crit Care 2005, 9: 204-211. 10.1186/cc2946PubMedCentralCrossRefPubMed
13.
go back to reference Stewart PA: Modern quantitative acid–base chemistry. Can J Physiol Pharmacol 1983, 61: 1444-1461.CrossRefPubMed Stewart PA: Modern quantitative acid–base chemistry. Can J Physiol Pharmacol 1983, 61: 1444-1461.CrossRefPubMed
14.
go back to reference Figge J, Mydosh T, Fencl V: Serum proteins and acid–base equilibria: a follow-up. J Lab Clin Med 1992, 120: 713-719.PubMed Figge J, Mydosh T, Fencl V: Serum proteins and acid–base equilibria: a follow-up. J Lab Clin Med 1992, 120: 713-719.PubMed
15.
go back to reference Rocktaeschel J, Morimatsu H, Uchino S, Goldsmith D, Poustie S, Story D, Gutteridge G, Bellomo R: Acid–base status of critically ill patients with acute renal failure: analysis based on Stewart–Figge methodology. Crit Care 2003, 7: R41-R45. 10.1186/cc2333CrossRef Rocktaeschel J, Morimatsu H, Uchino S, Goldsmith D, Poustie S, Story D, Gutteridge G, Bellomo R: Acid–base status of critically ill patients with acute renal failure: analysis based on Stewart–Figge methodology. Crit Care 2003, 7: R41-R45. 10.1186/cc2333CrossRef
16.
go back to reference Moviat M, van Haren F, van der Hoeven H: Conventional or physicochemical approach in intensive care unit patients with metabolic acidosis. Crit Care 2003, 7: R41-R45. 10.1186/cc2184PubMedCentralCrossRefPubMed Moviat M, van Haren F, van der Hoeven H: Conventional or physicochemical approach in intensive care unit patients with metabolic acidosis. Crit Care 2003, 7: R41-R45. 10.1186/cc2184PubMedCentralCrossRefPubMed
17.
go back to reference Villa P, Jiménez M, Soriano M, Manzanares J, Casasnovas P: Serum cystatin C concentration as a marker of acute renal dysfunction in critically ill patients. Crit Care 2005, 9: R139-R143. 10.1186/cc3044PubMedCentralCrossRefPubMed Villa P, Jiménez M, Soriano M, Manzanares J, Casasnovas P: Serum cystatin C concentration as a marker of acute renal dysfunction in critically ill patients. Crit Care 2005, 9: R139-R143. 10.1186/cc3044PubMedCentralCrossRefPubMed
18.
go back to reference Herget-Rosenthal S, Marggraf G, Husing J, Goring F, Pietruck F, Janssen O, Philipp T, Kribben A: Early detection of acute renal failure by serum cystatin C. Kidney Int 2004, 66: 1115-1122. 10.1111/j.1523-1755.2004.00861.xCrossRefPubMed Herget-Rosenthal S, Marggraf G, Husing J, Goring F, Pietruck F, Janssen O, Philipp T, Kribben A: Early detection of acute renal failure by serum cystatin C. Kidney Int 2004, 66: 1115-1122. 10.1111/j.1523-1755.2004.00861.xCrossRefPubMed
19.
go back to reference Hoffmann G, Czechowski M, Schoesser M, Schobersberger W: Procalcitonin amplifies inductible nitric oxyde synthase gene expression and nitric oxide production in vascular smooth muscle cells. Crit Care Med 2002, 30: 2091-2095. 10.1097/00003246-200209000-00023CrossRefPubMed Hoffmann G, Czechowski M, Schoesser M, Schobersberger W: Procalcitonin amplifies inductible nitric oxyde synthase gene expression and nitric oxide production in vascular smooth muscle cells. Crit Care Med 2002, 30: 2091-2095. 10.1097/00003246-200209000-00023CrossRefPubMed
20.
go back to reference Level C, Chauveau P, Guisset O, Cazin MC, Lasseur C, Gabinsky C, Winnock S, Montaudon D, Bedry R, Nouts C, et al.: Mass transfer, clearance and plasma concentration of procalcitonin during continuous venovenous hemofiltration in patients with septic shock and acute oliguric renal failure. Crit Care 2003, 7: R160-R166. 10.1186/cc2372PubMedCentralCrossRefPubMed Level C, Chauveau P, Guisset O, Cazin MC, Lasseur C, Gabinsky C, Winnock S, Montaudon D, Bedry R, Nouts C, et al.: Mass transfer, clearance and plasma concentration of procalcitonin during continuous venovenous hemofiltration in patients with septic shock and acute oliguric renal failure. Crit Care 2003, 7: R160-R166. 10.1186/cc2372PubMedCentralCrossRefPubMed
21.
go back to reference Naka T, Jones D, Baldwin I, Fealy N, Bates S, Goehl H, Morgera S, Neumayer HH, Bellomo R: Myoglobin clearance by super high-flux hemofiltration in a case of severe rhabdomyolysis: a case report. Crit Care 2005, 9: R90-R95. 10.1186/cc3034PubMedCentralCrossRefPubMed Naka T, Jones D, Baldwin I, Fealy N, Bates S, Goehl H, Morgera S, Neumayer HH, Bellomo R: Myoglobin clearance by super high-flux hemofiltration in a case of severe rhabdomyolysis: a case report. Crit Care 2005, 9: R90-R95. 10.1186/cc3034PubMedCentralCrossRefPubMed
22.
go back to reference Morgera S, Melzer C, Sobottke V, Vargas-Hein O, Zuckermann-Becker H, Bellomo R, Neumayer H: Renal replacement therapy with high cutoff hemofilters: impact of convection and diffusive on cytokine clearances and protein status. 24th International Symposium on Intensive Care and Emergency Medicine. Crit Care 2004, (Suppl 1):P151. 10.1186/cc2618 Morgera S, Melzer C, Sobottke V, Vargas-Hein O, Zuckermann-Becker H, Bellomo R, Neumayer H: Renal replacement therapy with high cutoff hemofilters: impact of convection and diffusive on cytokine clearances and protein status. 24th International Symposium on Intensive Care and Emergency Medicine. Crit Care 2004, (Suppl 1):P151. 10.1186/cc2618
23.
go back to reference Morgera S, Slowinski T, Melzer C, Sobottke V, Vargas-Hein O, Volk T, Zuckermann-Becker H, Wegner B, Muller JM, Baumann G, et al.: Renal replacement therapy with high cutoff hemofilters: impact of convection and diffusive on cytokine clearances and protein status. Am J Kidney Dis 2004, 43: 444-453. 10.1053/j.ajkd.2003.11.006CrossRefPubMed Morgera S, Slowinski T, Melzer C, Sobottke V, Vargas-Hein O, Volk T, Zuckermann-Becker H, Wegner B, Muller JM, Baumann G, et al.: Renal replacement therapy with high cutoff hemofilters: impact of convection and diffusive on cytokine clearances and protein status. Am J Kidney Dis 2004, 43: 444-453. 10.1053/j.ajkd.2003.11.006CrossRefPubMed
24.
go back to reference Venkataraman R, Subramanian S, Kellum JA: Clinical review: Extracorporeal blood purification in severe sepsis. Crit Care 2003, 7: 139-145. 10.1186/cc1889PubMedCentralCrossRefPubMed Venkataraman R, Subramanian S, Kellum JA: Clinical review: Extracorporeal blood purification in severe sepsis. Crit Care 2003, 7: 139-145. 10.1186/cc1889PubMedCentralCrossRefPubMed
Metadata
Title
Year in review: Critical Care 2004 – nephrology
Authors
Zaccaria Ricci
Claudio Ronco
Publication date
01-10-2005
Publisher
BioMed Central
Published in
Critical Care / Issue 5/2005
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc3791

Other articles of this Issue 5/2005

Critical Care 5/2005 Go to the issue